621
Participants
Start Date
April 17, 2024
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2027
Initiating daily oral PrEP during pregnancy
Group 1a will include pregnant women who initiate oral PrEP when already pregnant, at enrollment into the study.
Already using daily oral PrEP at the time of pregnancy diagnosis
Group 1b will include women already using daily oral PrEP at the time of pregnancy diagnosis and enrollment in the study.
Initiating injectable PrEP during pregnancy
Group 2a will include pregnant women who initiate injectable PrEP (CAB-LA) when already pregnant, at enrollment into the study.
Already using injectable PrEP (CAB-LA) at the time of pregnancy diagnosis
Group 2b will include women using injectable PrEP (CAB-LA) at the time of pregnancy diagnosis and enrollment into the study.
RECRUITING
Bwaila Distict Hospital, Lilongwe
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
United States President's Emergency Plan for AIDS Relief
FED
Ministry of Health, Malawi
OTHER_GOV
University of North Carolina, Chapel Hill
OTHER